Additionally, acquired events in both alleles of an MMR gene (pathogenic mutation or loss of heterozygosity) have been demonstrated to cause MMR deficiency in more than 50% of colorectal and endometrial tumours without a germline MMR gene mutation or MLH1 promoter methylation [24,25]. The gene discussed is MRC1; the disease is endometrium neoplasm.